ClinicalTrials.Veeva

Menu

The Effect of Deep Neuromuscular Blockade on Postoperative Shoulder Tip Pain After Laparoscopic Cholecystectomy

Yonsei University logo

Yonsei University

Status and phase

Completed
Phase 4

Conditions

Pain, Postoperative

Treatments

Drug: Rocuronium

Study type

Interventional

Funder types

Other

Identifiers

NCT02036827
3-2013-0210

Details and patient eligibility

About

The purpose of this study was to investigate whether there is any difference in incidence of shoulder tip pain after laparoscopic cholecystectomy between the groups with moderate neuromuscular block and deep neuromuscular block.

Full description

Laparoscopic cholecystectomy has become the gold standard treatment for gall bladder disease. However, 30-50% of patients suffer from shoulder tip pain, which might arise from diaphragm stretch due to pneumoperitoneum.

In the previous pilot study, working intra-abdominal space was increased in the condition of deep neuromuscular blockade. And thus investigators hypothesized that the depth of neuromuscular blockade can affect insufflation pressure and intra-abdominal volume, which result in the severity of diaphragm stretch and postoperative shoulder pain. In addition, the depth of neuromuscular blockade can alter pulmonary compliance.

Enrollment

108 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • physical status by American society of Anesthesiology; 1 or 2 patients
  • patients with benign gallbladder disease scheduled for laparoscopic cholecystectomy

Exclusion criteria

  • patient with myasthenia gravis
  • allergy to rocuronium or sugammadex
  • patient with shoulder pain disease (Ex. rotator cuff tear)
  • psychological disease
  • patients who cannot understand Korean

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

108 participants in 3 patient groups

moderate NMB + standard pressure
Active Comparator group
Description:
Investigators will administrate rocuronium until moderate neuromuscular blockade (Train of Four \>=1, Post-tetanic count\>=8) is established. And pneumoperitoneum will be maintained with standard-pressure 14 mmHg.
Treatment:
Drug: Rocuronium
deep NMB + standard pressure
Active Comparator group
Description:
Investigators will administrate rocuronium until deep neuromuscular blockade (Train of Four=0, Post-tetanic count\<=3) is established. And pneumoperitoneum will be maintained with standard-pressure 14 mmHg.
Treatment:
Drug: Rocuronium
deep NMB + low pressure
Active Comparator group
Description:
Investigators will administrate rocuronium until deep neuromuscular blockade (Train of Four=0, Post-tetanic count\<=3) is established. And pneumoperitoneum will be maintained with standard-pressure 8 mmHg.
Treatment:
Drug: Rocuronium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems